Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neutec Ilac Sanayi Ve Ticaret AS

www.neutec.com.tr/

Latest From Neutec Ilac Sanayi Ve Ticaret AS

Turkey's Abdi Ibrahim Beats Multinationals On Domestic Pharma Market

The Turkish pharmaceutical market reached $5.6bn in 2017. Despite strong competition from multinationals, Abdi Ibrahim, a local company, was market leader last year with a turnover of $380m. It was followed by Novartis and Pfizer.

Turkey Market Intelligence

Takeda’s Planned Emerging Markets Deal: India Yay Or Nay?

Takeda tantalizingly disclosed during its third quarter results that it has set aside funds for an acquisition worth around $450m in an undisclosed emerging market. What are the likely targets?

Emerging Markets Deals

Turkey Company Roundup: Biosimilar Pact, Keytruda Supply, Takeda Deal

TUBITAK (The Scientific and Technological Research Council of Turkey) will produce biosimilars with Nobel Ilac, MSD provides pembrolizumab free to 25 patients in Turkey, Abdi Ibrahim intensifies its R&D efforts, and Takeda purchases a portfolio of new products.

BioPharmaceutical Turkey

Deals Shaping The Medical Industry, March 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced February 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Gastrointestinal
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Neutec
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Turkey
  • Parent & Subsidiaries
  • Neutec Ilac Sanayi Ve Ticaret AS
  • Senior Management
  • Mahmut Bilgic, CEO
  • Contact Info
  • Neutec Ilac Sanayi Ve Ticaret AS
    Phone: 212 484 28 60
    Yildiz Tech. Univ. Campus Davutpasa
    Technopark D1
    Istanbul,
    Turkey
Advertisement
Advertisement
UsernamePublicRestriction

Register